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Introduction
Benign prostatic hyperplasia (BPH) and erectile dys-
function (ED) are 2 major disease entities in urology.
Some men with BPH have voiding symptoms, i.e.
lower urinary tract symptoms (LUTS). With aging,
the prevalence of both LUTS and ED increases.1–3
Conceptually, there may be some correlation between
voiding and penile erection, since both functions are
innervated by similar spinal cord levels, i.e. by both
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parasympathetic and sympathetic nerves. Although
many previous studies revealed some relationship
between LUTS and sexual dysfunction,4–6 recent reports
showed that LUTS had no direct effect on sexual
dysfunction. Both LUTS and sexual dysfunction are
simply more common in the elderly.7,8 Because of pre-
vious contention, we conducted this study to explore
the possible relationship between voiding and erectile
function (EF), by means of questionnaires, in patients
with BPH.
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Methods
Study population
From March 2001 to January 2002, 72 inpatients
(mean age, 73 years; range, 43–93 years) with BPH
who were admitted for transrectal ultrasound-guided
biopsy of the prostate were enrolled in the study. Age,
concurrent illnesses (diabetes mellitus, hypertension,
hyperlipidemia and coronary artery disease), and BPH
medication were recorded.
Study questionnaires
The 2 study questionnaires — the American Uro-
logical Association Symptom Index (AUA-SI) and
International Index of EF (IIEF-15)9,10 — were self-
administered by patients. In addition, patients were
asked whether or not they had ED, which was de-
fined as the inability to achieve and/or maintain an
erection sufficient for satisfactory sexual perfor-
mance.11 AUA-SI scores were divided into 3 catego-
ries: irritative (3 questions); obstructive (4 questions);
and total. IIEF-15 scores were divided into 6 cate-
gories: EF; orgasmic function [OF]; sexual desire
[SD]; intercourse satisfaction [IS]; overall satisfac-
tion [OS]; and total.
Statistical analysis
AUA-SI and IIEF-15 scores for the ED and non-ED
groups were evaluated and compared using the
Mann-Whitney U test; ages were compared using a
2-sided t test. The correlation between AUA-SI and
IIEF-15 categories was assessed using Pearson’s cor-
relation test. Further, AUA-SI and IIEF-15 scores
were categorized according to the severity of symp-
toms: the “severity” of AUA-SI scores9 was consid-
ered mild (scores 0–7), moderate (8–19), or severe
(20–35); whereas that of IIEF-15 scores12 was consi-
dered as no ED (EF-domain score 26–30), mild (22–
25), mild to moderate (17–21), moderate (11–16),
or severe (6–10).
Age was also assessed as a single variable, and data
for age, AUA-SI score, and EF-domain score were ex-
pressed as mean ( standard deviation. Statistical signi-
ficance was evaluated by the Kruskal-Wallis test, and
a p value of less than 0.05 was considered significant.
Results
Demographic data
Fifty of the 72 patients answered all items on the
questionnaires. The other 22 patients gave partial
answers or no answers at all and were excluded.
Thirty-one patients had concurrent illnesses (diabetes
mellitus [n = 12]; hypertension [n = 20]; hyperlipidemia
[n = 5]; and/or coronary artery disease [n = 9]), and
40 were taking medication for BPH (tamsulosin or
doxazosin [n = 37]; finasteride [n = 3]).
Questionnaire findings
Of the 50 men who completed the questionnaires, 28
(56%) aged from 68–93 years (mean, 75.8 years)
answered that they had ED. Among the 22 men
aged 43–80 years (mean, 70.0 years) who denied
having ED, 17 (77%) had an EF-domain score of less
than 26; a score of 26 is considered the threshold
level below which erection is normal.12 Patients with
versus those without concurrent illnesses were more
likely to have ED (64.5% vs 26.3%), and the prevalence
of ED was similar in patients taking versus those
not taking BPH medication. According to chart
recordings or interviews, no new-onset ED was
attributed to BPH medication. Moreover, patients
with ED were significantly older than those without
ED (Table 1).
Scores for 3 categories of the AUA-SI question-
naire, and 6 categories of the IIEF-15 questionnaire,
together with patient ages, are listed as mean values
(( standard deviation) in Table 1. There was no sig-
nificant difference in voiding symptoms between pa-
tients with and those without ED, whereas each of
the 5 domain scores, and total scores, on the IIEF-15
questionnaire were significantly different between
the ED and non-ED groups (Table 1).
Between-questionnaire differences
No significant correlations between AUA-SI and
IIEF-15 scores were identified (Table 2). In addition,
analyses according to disease severity (mild, moderate
or severe), as determined by AUA-SI score, revealed
no statistically significant differences regarding pa-
tient ages, or scores in each of the IIEF-15 catego-
ries (Table 3). Similarly, analyses according to disease
severity, as determined by scores on the IIEF-15 EF
domain, revealed no statistically significant differences
regarding scores in each of the AUA-SI categories;
however, significant differences in patient age were
noted between the various subgroups categorized
according to EF-domain disease severity (Table 4).
Discussion
BPH and ED are 2 of the major disease entities in
urology, and both are common in elderly men.
Physiologically, urination and EF are controlled by
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similar levels of spinal-cord innervation. BPH becomes
clinically significant later in a man’s life: by age 60
years, approximately 50% of men have histologic
evidence of BPH, whereas all men have such evidence
by age 80 years.13 Men with LUTS tend to be older
(mean age > 60 years) than those who present with ED
(mean age usually < 60 years).14–17
A potential correlation between LUTS and ED
remains questionable. Earlier studies showed some
correlation between LUTS and ED,4–6 and a recent
trial reported an increased odds ratio for LUTS
indicating an increased severity of ED.18 However,
some studies showed that the correlation between
BPH and ED is coincidental, simply because these
2 conditions are more common in elderly individ-
uals.7,8,19–21 Sexual function may be more closely re-
lated to the effect that LUTS have on quality of life,
rather than to LUTS themselves.22 In addition, the
effect of severe irritative symptoms, or the presence of
BPH-related morbidity (e.g. bladder stones), increases
the incidence of ED.3 Thus, unless complications
develop, the correlation between BPH and ED is
usually coincidental. In our study, scores for irritative
urinary symptoms did not correlate with EF-domain
scores in BPH patients, possibly because such symp-
toms were not severe, and there was no BPH-related
morbidity. Although there was a trend towards de-
creasing IIEF-15 scores with increasing AUA-SI
scores (Table 3), this was not statistically significant.
Further, there was a tendency towards increasing
irritative AUA-SI scores with decreasing EF-domain
scores (Table 4). We propose that the relatively small
number of patients enrolled in the study may have
influenced the statistical results since it was difficult to
Table 1. Comparison of ages and scores in 3 categories of the AUA-SI questionnaire and 6 categories of the IIEF-15
questionnaire in patients with benign prostatic hyperplasia who had erectile dysfunction (ED) or who did not have ED
All patients ED Non-ED p
(n = 50) (n = 28) (n = 22)
AUA-SI
Irritative 7.8 ( 3.7 8.5 (  3.7 6.9 ( 3.7 0.195*
Obstructive 8.4 ( 5.6 8.5 (  4.7 8.3 ( 6.8 0.702*
Total† 16.3 (  8.2 17.2 ( 6.8 15.2 ( 9.8 0.428*
IIEF-15
Erectile function 12.1 ( 10.1 7.6 (  7.6 17.2 ( 10.3 0.033*
Orgasmic function 3.7 ( 3.8 2.4 (  3.1 5.5 ( 4.0 0.000*
Sexual desire 4.4 ( 2.0 3.5 (  1.9 5.6 ( 2.0 0.003*
Intercourse satisfaction 4.5 ( 4.4 3.0 (  3.5 6.5 ( 4.7 0.009*
Overall satisfaction 4.4 ( 2.6 3.6 (  2.0 5.5 ( 2.9 0.024*
Total‡ 29.4 ( 22.2 20.2 ( 17.2 41.0 ( 21.6 0.001*
Age, yr 73.0 ( 12.2 75.8 ( 6.5 70.0 ( 10.3 0.033§
*p value vs non-ED group using Mann-Whitney U test; †total of irritative and obstructive scores; ‡total of scores on all 5 domains on the IIEF-
15 questionnaire; §p value vs non-ED group using 2-sided t test. All data are expressed as mean ( standard deviation. AUA-SI = American Urological
Association Symptom Index; IIEF-15 = International Index of Erectile Function-15.




Erectile function –0.214 –0.134 –0.202
Orgasmic function –0.215 –0.199 –0.249
Sexual desire –0.235 –0.121 –0.190
Intercourse satisfaction –0.173 –0.162 –0.210
Overall satisfaction –0.174 –0.119 –0.147
Total† –0.193 –0.144 –0.195
*Total of irritative and obstructive scores; †total of scores on all 5 domains on the IIEF-15 questionnaire. All data are expressed as Pearson correlation
coefficients. AUA-SI = American Urological Association Symptom Index; IIEF-15 = International Index of Erectile Function-15.
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perform additional, age-adjusted division of AUA-SI
and EF-domain scores to indicate disease severity.
Most of our patients took _-adrenergic blockers
for the treatment of symptomatic BPH, and there
seemed to be no increased incidence of ED. This
concurs with the literature, in which treatments for
BPH (whether medications or surgery) had no
meaningful impact on sexual function.3,19 In addi-
tion, angiotensin-converting enzyme inhibitors or
histamine2-blockers used in patients with hyperten-
sion or heart disease seemed to have no influence
on the incidence of ED.23
An interesting finding in this study was patients who
subjectively stated that they had no ED but who,
nonetheless, had low EF-domain scores. In our trial,
ED was defined as the inability to achieve and/or
maintain an erection sufficient for satisfactory sexual
performance.11 However, when a broader base of sexual
activity is used to define ED, as in some reports, to in-
clude touch, caressing, masturbation, and the absence
of sexual activity during the previous 4 weeks, the
incidence of ED increases.7,24–26 In our study, 77% of
patients with a subjectively reported absence of ED
actually had an EF-domain score of less than 26 and
should therefore have been classified as having ED.12
Considering cultural differences, a cut-off score of 15
on the IIEF-15 questionnaire may be more appropriate
for categorizing ED in Taiwanese individuals.27 Although
the rate of ED decreased from 77% to 59% after
adjustment according to criteria reported by Chang et
al,27 the rate was still high enough to reflect cultural
differences and traditional thoughts about ED.
In conclusion, the present study suggests that, with
use of the objective AUA-SI and IIEF-15 questionnaires,
no correlation exists between voiding function and EF
in patients with BPH. Both LUTS and ED may simply
appear concomitantly in elderly men as a normal aspect
of aging. However, a study with a larger number of
patients is needed to clarify this issue.
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